BIOMARIN PHARMACEUTICAL INC Patent Applications Pending
260 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2026-02-27: Application PCTUS2026016990; Invention TREATMENT OF NEURONAL CEROID LIPOFUSCINOSIS 3 (CLN3) WITH TPP1; Applicant BIOMARIN PHARMACEUTICAL INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2025-12-05: Application 19490710; Invention HIGH THROUGHPUT SCREEN FOR GENETIC VARIANTS ASSOCIATED WITH SHORT STATURE; Applicant BIOMARIN PHARMACEUTICAL INC.; Status Application Undergoing Preexam Processing.
- 2025-11-13: Application PCTUS2025055241; Invention SMALL MOLECULES TO TREAT ALPHA-1-ANTITRYPSIN (A1AT) DEFICIENCY IN SPECIFIC PATIENT POPULATIONS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2025-11-07: Application PCTUS2025054672; Invention COMPOSITIONS AND METHODS FOR TREATMENT OF CALCIPHYLAXIS; Applicant BIOMARIN PHARMACEUTICAL INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | PCTUS2026016990 | TREATMENT OF NEURONAL CEROID LIPOFUSCINOSIS 3 (CLN3) WITH TPP1 | BIOMARIN PHARMACEUTICAL INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | GUILLERMO SERATTI | United States |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |